Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
FEMY | US
-0.03
-2.63%
Healthcare
Medical Instruments & Supplies
30/06/2024
04/10/2024
1.11
1.11
1.13
1.10
Femasys Inc. a biomedical company develops novel solutions for women's healthcare market in the United States and internationally. The company provides FemVue saline-air device a contrast-generating product in the United States Canada Japan and Hong Kong; FemCath a cornual balloon catheter a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv a biopsy device for endocervical curettage which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions such as FemBloc and FemChec; FemaSeed an artificial insemination solution; and FemEMB a product candidate for endometrial sampling in support of uterine cancer detection testing. In addition the company provides non-surgical product technologies. It offers its infertility products to obstetrics-gynecological physicians related healthcare professionals women's healthcare provider organizations and reproductive endocrinologists. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee Georgia.
View LessValue Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
25.7%1 month
42.2%3 months
71.1%6 months
83.7%-
-
2.21
0.63
0.35
0.24
19.41
-
-16.12M
24.68M
24.68M
-
-2.02K
-
-30.90
-138.37
5.21
3.91
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.13
Range1M
0.20
Range3M
0.43
Rel. volume
0.54
Price X volume
64.52K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Meihua International Medical Technologies Co. Ltd. Ordinary Shares | MHUA | Medical Instruments & Supplies | 1.04 | 27.14M | 1.96% | 2.81 | 5.01% |
Inspira Technologies OXY B.H.N. Ltd | IINN | Medical Devices | 1.37 | 25.35M | 4.98% | n/a | 40.92% |
Retractable Technologies Inc | RVP | Medical Instruments & Supplies | 0.751 | 22.48M | -2.43% | n/a | 1.63% |
Ekso Bionics Holdings Inc | EKSO | Medical Instruments & Supplies | 1.04 | 22.41M | 2.97% | n/a | 55.49% |
Beyond Air Inc | XAIR | Medical Devices | 0.422 | 19.63M | 26.42% | n/a | 109.74% |
NEXGEL INC. | NXGL | Medical Instruments & Supplies | 2.51 | 15.87M | 4.15% | n/a | 71.87% |
Cutera Inc | CUTR | Medical Devices | 0.7497 | 15.19M | -0.04% | n/a | -201.18% |
Microbot Medical Inc | MBOT | Medical Instruments & Supplies | 0.9011 | 14.87M | -0.99% | n/a | 2.44% |
Innovative Eyewear Inc. | LUCY | Medical Instruments & Supplies | 8.19 | 12.86M | -7.98% | n/a | 0.00% |
PAVmed Inc | PAVM | Medical Devices | 1.27 | 12.64M | 1.60% | n/a | -67.66% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.89 | 19.79M | -2.50% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 1.0599 | 19.14M | -0.93% | n/a | 5.48% |
Rocky Mountain Chocolate Factory Inc | RMCF | Confectioners | 2.04 | 15.49M | 1.49% | n/a | 38.66% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.695 | 8.47M | -4.15% | n/a | 16.03% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.24 | 7.69 | Cheaper |
Ent. to Revenue | 19.41 | 64.13 | Cheaper |
PE Ratio | - | 50.95 | - |
Price to Book | 2.21 | 6.11 | Cheaper |
Dividend Yield | - | 1.34 | - |
Std. Deviation (3M) | 71.13 | 55.82 | Riskier |
Debt to Equity | 0.63 | 0.86 | Cheaper |
Debt to Assets | 0.35 | 0.26 | Expensive |
Market Cap | 24.68M | 9.95B | Emerging |